On August 14, 2017, Amneal announced a recall of some lots of Lorazepam 2 mg/mL oral
concentrate because of a defect in the dropper markings. In a few instances, the dropper was
printed with the dose markings in reverse number order, had no dose markings, or had dose
markings that were shifted. There is no safety issue with the drug itself.
*Please see attached PDF for more information.